Prevention of type 2 diabetes: issues and strategies for identifying persons for interventions.
Because of the ongoing worldwide diabetes epidemic and new evidence that type 2 diabetes can be prevented or delayed, we are compelled to implement prevention efforts. Health policy makers need to bridge the evidence gap left by prevention trials that did not include all groups at risk for developing diabetes. Intensive interventions may be appropriate for groups with similar risk as those studied in clinical trials, while less intense efforts may be considered for those groups that have not been studied. Factors such as structure of the health care system and individual social and economic situations may influence the implementation of prevention efforts. Currently, no universally validated and well-tested method exists to identify all people at high risk for developing diabetes. However, groups that will be targeted for prevention efforts can be identified through several reasonable strategies.
Engelgau
Michael M
MM
Division of Diabetes Plantation, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA. mxe1@cdc.gov
Colagiuri
Stephen
S
Ramachandran
Ambady
A
Borch-Johnsen
Knut
K
Narayan
K M Venkat
KM
D002986:Clinical Trials as Topic; D003924:Diabetes Mellitus, Type 2 / Q000517:prevention & control*; D016640:Diabetes, Gestational; D005260:Female; D018149:Glucose Intolerance / Q000517:prevention & control; D006801:Humans; D011247:Pregnancy; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment